Dizocilpine derivatives as peripheral NMDA receptor antagonists
Sylvia Cohen-Kaminsky, Le Plessis-Robinson (FR); Marc Humbert, Le Plessis-Robinson (FR); Sebastien Dumas, Le Plessis-Robinson (FR); Gilles Bru-Mercier, Le Plessis-Robinson (FR); Samir Messaoudi, Chatenay-Malabry (FR); Jean-Daniel Brion, Chatenay-Malabry (FR); Mouad Alami, Chatenay-Malabry (FR); and Gilles Galvani, Chatenay-Malabry (FR)
Assigned to INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), Paris (FR); CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), Paris (FR); UNIVERSITÉ PARIS-SACLAY, Saint Aubin (FR); ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS (APHP), Paris (FR); and HOPITAL MARIE LANNELONGUE, Le Plessis-Robinson (FR)
Filed by INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), Paris (FR); CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), Paris (FR); UNIVERSITÉ PARIS-SACLAY, Saint Aubin (FR); ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS (APHP), Paris (FR); and HOPITAL MARIE LANNELONGUE, Le Plessis-Robinson (FR)
Filed on Apr. 6, 2023, as Appl. No. 18/296,543.
Application 18/296,543 is a division of application No. 17/825,082, filed on May 26, 2022, granted, now 11,944,616.
Application 17/825,082 is a division of application No. 16/308,654, granted, now 11,376,245, issued on Jul. 5, 2022, previously published as PCT/EP2017/064409, filed on Jun. 13, 2017.
Claims priority of application No. 16305712 (EP), filed on Jun. 13, 2016.
Prior Publication US 2023/0285381 A1, Sep. 14, 2023
